T cells

Autolomous and Vineti form strategic partnership to deliver end to end supply chain management solutions for cell and gene therapy sector

Autolomous LTD, the market leading developer of critical manufacturing management systems for cell and gene therapies, and Vineti, a provider of leading digital enterprise platforms for cell and gene therapy supply chains, today announce a non-exclusive collaborative partnership.

Read More
May 9, 2019

Cell and gene therapy news: some recent highlights

Things keep moving fast in the world of cell and gene therapy. Here are a few of the recent developments...

April 30, 2019

Q1 update from Vineti

As 2019 shapes up to be yet another landmark year for advanced therapies, Vineti is hard at work on our...

April 23, 2019

Cell therapy labels that work — pointers to keep your patient and your product in sync

In cell therapy, smarter labeling means greater safety and speed. If you’re a cell therapy developer, you have a make-or-break...

April 23, 2019

Setting standards — three essential starting points

Welcome to the Vineti blog! This is our first post, and we’re looking forward to sharing insights, perspectives and company updates here....